Impact of Biophoton Therapy on Patients With Brain Disorders (Alzheimer's)
—an IRB approved clinical study
Listed on clinicaltrials.gov (NCT06147999) - click here.
Enrolling patients with brain-related disorders, such as Alzheimer’s disease, Dementia, Traumatic Brain Injury, and Parkinson’s disease: First Institute of All Medicines, a non-profit organization, is conducting a clinical study. This is a double blinded, placebo-controlled randomized clinical study to investigate whether biophoton generators may be able to help to recover brain and body functions. This is an IRB-approved clinical study.
Medical research staff of First Institute of All Medicines will be conducting this study using research facilities with the Biophoton-powered Tesla MedBed at the wellness center.
Our study participants and their caregiver guests will sleep on a bed powered by biophoton generators.
Study Specifics:
OR
CONTACT:
Jessica Jackson, Clinical Study Coordinator
First Institute of All Medicines
139 Pittsburgh Road, Butler, PA 16001.
Direct Line: 302-922-2486
Email: Jessica.Jackson@FirstAllMed.org
For general questions, please email: Info@FirstAllMed.org
For clinical research information, please visit: www.FirstAllMed.org
For product information, please visit: www.TeslaBioHealing.com
©2023 Tesla BioHealing. All rights reserved. Privacy Policy
Related Study: Impact of Biophoton Energy on Stroke Recovery —an IRB approved clinical study Listed on clinicaltrials.gov (NCT05898334) - LEARN MORE HERE